Zealand Pharma, a biotech company with leading scientific expertise in turning peptides into medicines, approached LoBo & Petrocine to conduct a study on short bowel syndrome and collect data and insights on gender, age, sentiment, geographical significance, as well as marketing opportunities.
LoBo & Petrocine launched a thorough two-month investigation, which included a real-time social media analytics platform to track and analyze mentions of desired keywords and crawl social media networks such as Facebook, Twitter, YouTube, Instagram and several others. Additionally, we developed a strategic marketing and competitive inventory specifically for Zealand Pharma, which included manual research into short bowel syndrome-related associations, foundations, societies, patient forums, blogs, advertisements in the disease area, competitors and more. All websites were ranked using an independent third party, Alexa rankings.
The comprehensive study uncovered a wide variety of insights into short bowel syndrome, from the disease itself to the many who suffer from it. It also uncovered a major key opinion leader on SBS, Andy Jablonski, CEO of the Short Bowel Syndrome Foundation. The study also showed patients’ frustrations in dealing with SBS and a willingness to take the risks of adverse events to get off of TPN in pursuit of a better quality of life. These findings have been instrumental to Zealand Pharma as they consider next steps in their efforts to combat this disease.
• Market Research
• Measurement & Analytics Audit
• Custom Report & Dashboard Development